Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 282

    1.

    The effect of recombinant human granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity in chronic severe neutropenia.

    Ganser A, Ottmann OG, Erdmann H, Schulz G, Hoelzer D.

    Ann Intern Med. 1989 Dec 1;111(11):887-92.PMID: 2683920 [PubMed - indexed for MEDLINE]Related articles

    2.

    Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia.

    Welte K, Zeidler C, Reiter A, Müller W, Odenwald E, Souza L, Riehm H.

    Blood. 1990 Mar 1;75(5):1056-63.PMID: 1689595 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy.

    Lieschke GJ, Maher D, Cebon J, O'Connor M, Green M, Sheridan W, Boyd A, Rallings M, Bonnem E, Metcalf D, et al.

    Ann Intern Med. 1989 Mar 1;110(5):357-64.PMID: 2644886 [PubMed - indexed for MEDLINE]Related articles

    4.

    Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor.

    Glaspy JA, Baldwin GC, Robertson PA, Souza L, Vincent M, Ambersley J, Golde DW.

    Ann Intern Med. 1988 Nov 15;109(10):789-95.PMID: 2461131 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.

    Antman KS, Griffin JD, Elias A, Socinski MA, Ryan L, Cannistra SA, Oette D, Whitley M, Frei E 3rd, Schnipper LE.

    N Engl J Med. 1988 Sep 8;319(10):593-8.PMID: 3045544 [PubMed - indexed for MEDLINE]Related articles

    7.

    Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.

    Lieschke GJ, Maher D, O'Connor M, Green M, Sheridan W, Rallings M, Bonnem E, Burgess AW, McGrath K, Fox RM, et al.

    Cancer Res. 1990 Feb 1;50(3):606-14.PMID: 2404573 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase I/II trial.

    Ganser A, Völkers B, Greher J, Ottmann OG, Walther F, Becher R, Bergmann L, Schulz G, Hoelzer D.

    Blood. 1989 Jan;73(1):31-7.PMID: 2642714 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy.

    Herrmann F, Schulz G, Wieser M, Kolbe K, Nicolay U, Noack M, Lindemann A, Mertelsmann R.

    Am J Med. 1990 Jun;88(6):619-24.PMID: 2189305 [PubMed - indexed for MEDLINE]Related articles

    10.

    A pilot study of low-dose recombinant human granulocyte-macrophage colony-stimulating factor in chronic neutropenia.

    Kaczmarski RS, Pozniak A, Lakhani A, Harvey E, Mufti GJ.

    Br J Haematol. 1993 Jun;84(2):338-40.PMID: 8398839 [PubMed - indexed for MEDLINE]Related articles

    11.

    Intervention treatment of established neutropenia with human recombinant granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in patients undergoing cancer chemotherapy.

    Gerhartz HH, Stern AC, Wolf-Hornung B, Kazempour M, Schmetzer H, Gugerli U, Jones TC, Wilmanns W.

    Leuk Res. 1993 Feb;17(2):175-85.PMID: 8429694 [PubMed - indexed for MEDLINE]Related articles

    12.

    A phase I/II trial of recombinant granulocyte-macrophage colony-stimulating factor for children with aplastic anemia.

    Guinan EC, Sieff CA, Oette DH, Nathan DG.

    Blood. 1990 Sep 15;76(6):1077-82.PMID: 2205306 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    In vitro and in vivo action of recombinant human GM-CSF (rhGM-CSF) in patients with myelodysplastic syndromes.

    Hoelzer D, Ganser A, Völkers B, Greher J, Walther F.

    Blood Cells. 1988;14(2-3):551-9.PMID: 3067785 [PubMed - indexed for MEDLINE]Related articles

    15.

    Congenital neutropenia: a case study.

    Daghistani D, Jimenez JJ, Toledano SR, Cirocco RE, Yunis AA.

    Am J Pediatr Hematol Oncol. 1990 Summer;12(2):210-4.PMID: 1696074 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Changes in neutrophil counts and functions after the administration of recombinant human granulocyte colony-stimulating factor in a patient with chronic idiopathic neutropenia]

    Sai M, Kawanishi Y, Kuriyama K, Kuratsuji T, Toyama K.

    Rinsho Ketsueki. 1990 Apr;31(4):484-6. Japanese. PMID: 1696326 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy.

    Herrmann F, Schulz G, Wieser M, Kolbe K, Nicolay U, Noack M, Lindemann A, Mertelsmann R.

    Haematol Blood Transfus. 1990;33:717-23.PMID: 2182461 [PubMed - indexed for MEDLINE]Related articles

    19.

    Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial.

    Negrin RS, Haeuber DH, Nagler A, Olds LC, Donlon T, Souza LM, Greenberg PL.

    Ann Intern Med. 1989 Jun 15;110(12):976-84.PMID: 2471429 [PubMed - indexed for MEDLINE]Related articles

    20.

    Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation.

    Nemunaitis J, Singer JW, Buckner CD, Durnam D, Epstein C, Hill R, Storb R, Thomas ED, Appelbaum FR.

    Blood. 1990 Jul 1;76(1):245-53.PMID: 2194592 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data